Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Milan, Italy.
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):411-413. doi: 10.1002/ccd.28466. Epub 2019 Aug 27.
Patients presenting with cardiogenic shock and severe combined aortic and mitral regurgitation represent a major clinical challenge. Therapeutic options are limited in this setting as they are often deemed inoperable due to prohibitive risk for surgery, while mechanical circulatory support is usually contraindicated or technically challenging. Medical therapy, on the other hand, is associated with high-mortality rates. Therefore, percutaneous therapies may represent an appealing alternative. Here, we present a "one-stop-shop" totally percutaneous approach for severe aortic and mitral regurgitation in a patient with cardiogenic shock.
患有心原性休克和严重合并性主动脉瓣和二尖瓣反流的患者代表了一个主要的临床挑战。在这种情况下，治疗选择有限，因为由于手术风险过高，通常被认为不适合手术，而机械循环支持通常是禁忌的或具有技术挑战性。另一方面，药物治疗与高死亡率相关。因此，经皮治疗可能是一种有吸引力的替代方法。在这里，我们介绍了一种“一站式”的经皮方法，用于治疗心原性休克合并严重主动脉瓣和二尖瓣反流的患者。
